The IGG4-Related Disease Market is on an upward trajectory, expected to reach a staggering USD 6.08 billion by 2035, marking a significant increase from USD 2.67 billion in 2024. This impressive growth signifies a compound annual growth rate (CAGR) of 7.78%, reflecting both rising awareness and advancements in treatment options. As healthcare systems adapt to these changes, the market is...